SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
| C/O FORRESTER RESEARCH, INC. |
| 60 ACORN PARK DRIVE |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
06/01/2020
|
3. Issuer Name and Ticker or Trading Symbol
FORRESTER RESEARCH, INC.
[ FORR ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
| Chief Information Officer |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Common Stock |
3,161 |
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Non-Qualified Stock Option (Right to Buy) |
08/01/2018 |
07/31/2024 |
common stock |
300 |
38.43 |
D |
|
| Non-Qualified Stock Option (Right to Buy) |
08/03/2019 |
08/02/2025 |
common stock |
1,476 |
33.16 |
D |
|
| Restricted Stock Units |
08/01/2020 |
|
common stock |
1,112 |
|
D |
|
| Restricted Stock Units |
08/01/2021 |
|
common stock |
593 |
|
D |
|
| Restricted Stock Units |
08/01/2022 |
|
common stock |
383 |
|
D |
|
| Restricted Stock Units |
03/01/2021 |
|
common stock |
250 |
|
D |
|
| Restricted Stock Units |
03/01/2022 |
|
common stock |
250 |
|
D |
|
| Restricted Stock Units |
03/01/2023 |
|
common stock |
250 |
|
D |
|
| Restricted Stock Units |
09/03/2020 |
|
common stock |
290 |
|
D |
|
| Explanation of Responses: |
|
|
|
|
|
|
| Remarks: |
|
|
Maite Garcia, attorney-in-fact for Michael Kasparian |
06/02/2020 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
I hereby constitute and appoint each of Ryan Darrah, Maite Garcia and Jed
Rosenkrantz signing singly, my true and lawful attorney-in-fact to:
(1) execute for and on my behalf, in my capacity as an officer and/or director
of Forrester Research, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on my behalf that may be necessary
or desirable to complete and execute any such Form 3, 4 or 5 and timely file
such form with the United States Securities and Exchange Commission and any
stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be to my benefit,
in my best interest, or that I am legally required to do, it being understood
that the documents executed by such attorney-in-fact on my behalf pursuant to
this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's
discretion.
I hereby grant to such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper
to be done in the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as I might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. I acknowledge that the
attorney-in-fact, in serving in such capacity at my request, are not assuming,
nor is the Company assuming, any of my responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until I am no
longer required to file Forms 3, 4 and 5 with respect to my holdings of and
transactions in Company securities, unless I earlier revoke it in a signed
writing delivered to the attorneys-in-fact. Upon signature of this Power of
Attorney, I hereby revoke all previous powers of attorney granted concerning the
subject matter herein.
IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of
this 26th day of May, 2020.
Signature
/s/Michael Kasparian
Michael Kasparian
Print Name
